Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain on propofol injection and propofol dose for endoscopic sedation
ChiCTR2500100172Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Chongqing Medical University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol in procedural pain and propofol injection site pain (PISP) (2 arms), sponsored by The Third Affiliated Hospital of Chongqing Medical University. Primary endpoints: Pain on propofol injection and Total dose of propofol. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
procedural painpropofol injection site pain (PISP)
Beyond the preview
Go deeper on ChiCTR2500100172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100172.